DK1293507T3 - Fremgangsmåde til fremstilling af krystaller - Google Patents

Fremgangsmåde til fremstilling af krystaller

Info

Publication number: DK1293507T3
Authority: DK; Denmark
Prior art keywords: producing crystals; crystals; producing
Prior art date: 2000-05-15

Application number

DK01930131T

Other languages

English (en)

Inventor

Hideo Hashimoto

Hideaki Maruyama

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-15

Filing date

2001-05-15

Publication date

2007-12-27

2001-05-15 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2007-12-27 Application granted granted Critical

2007-12-27 Publication of DK1293507T3 publication Critical patent/DK1293507T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Crystallography & Structural Chemistry (AREA)
Materials Engineering (AREA)
Metallurgy (AREA)
Bioinformatics & Cheminformatics (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK01930131T 2000-05-15 2001-05-15 Fremgangsmåde til fremstilling af krystaller DK1293507T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2000141670		2000-05-15
PCT/JP2001/004014 WO2001087874A1 (en)	2000-05-15	2001-05-15	Process for producing crystal

Publications (1)

Publication Number	Publication Date
DK1293507T3 true DK1293507T3 (da)	2007-12-27

Family

ID=18648753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01930131T DK1293507T3 (da)	2000-05-15	2001-05-15	Fremgangsmåde til fremstilling af krystaller

Country Status (12)

Country	Link
US (4)	US7169799B2 (da)
EP (3)	EP1897877B1 (da)
KR (2)	KR101035534B1 (da)
CN (2)	CN100562318C (da)
AU (1)	AU2001256732A1 (da)
CA (3)	CA2762960C (da)
CY (1)	CY1107198T1 (da)
DE (1)	DE60131649T2 (da)
DK (1)	DK1293507T3 (da)
ES (3)	ES2521690T3 (da)
PT (1)	PT1293507E (da)
WO (1)	WO2001087874A1 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN100562318C (zh) *	2000-05-15	2009-11-25	武田药品工业株式会社	晶体的制备方法
AU2001276721A1 (en) *	2000-08-04	2002-02-18	Takeda Chemical Industries Ltd.	Salts of benzimidazole compound and use thereof
TWI290922B (en)	2000-12-01	2007-12-11	Takeda Chemical Industries Ltd	Production method of crystals
AU2003273000A1 (en) *	2002-10-16	2004-05-04	Takeda Pharmaceutical Company Limited	Stable solid preparations
EP1572680A2 (en) *	2002-12-19	2005-09-14	Eva Pharmaceutical Industries Ltd.	Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation.
ATE508747T1 (de) *	2003-03-10	2011-05-15	Eisai R&D Man Co Ltd	C-kit kinase-hemmer
SE0400410D0 (sv) *	2004-02-20	2004-02-20	Astrazeneca Ab	New compounds
EP1768668A2 (en)	2004-06-16	2007-04-04	Tap Pharmaceutical Products, Inc.	Multiple ppi dosage form
KR20070112464A (ko) *	2005-03-22	2007-11-26	다이이찌 산쿄 가부시키가이샤	1-알킬피롤리딘 구조를 갖는 카르바페넴 유도체의 제조방법
WO2006121151A1 (ja) *	2005-05-13	2006-11-16	Daiichi Sankyo Company, Limited	１－メチルカルバペネム化合物の結晶
CA2611261A1 (en) *	2005-06-07	2006-12-14	Takeda Pharmaceutical Company Limited	Crystal of salt of benzimidazole compound
JPWO2007074909A1 (ja)	2005-12-28	2009-06-04	武田薬品工業株式会社	放出制御固形製剤
WO2008081891A1 (ja)	2006-12-28	2008-07-10	Takeda Pharmaceutical Company Limited	口腔内崩壊性固形製剤
BRPI0818286A2 (pt) *	2007-10-12	2020-08-11	Takeda Pharmaceuticals North America, Inc.	métodos de tratamento de distúrbios gastrointestinais independente da ingestão de alimento.
US8214093B2 (en) *	2007-11-04	2012-07-03	GM Global Technology Operations LLC	Method and apparatus to prioritize transmission output torque and input acceleration for a hybrid powertrain system
JP2011507977A (ja) *	2007-12-31	2011-03-10	武田薬品工業株式会社	（ｒ）−２−［［［３−メチル−４−（２，２，２−トリフルオロエトキシ）−２−ピリジニル］メチル］スルフィニル］−１ｈ−ベンズイミダゾールの溶媒和物結晶形
NZ588379A (en) *	2008-03-10	2012-07-27	Takeda Pharmaceutical	Crystal of benzimidazole compound
WO2010039885A2 (en) *	2008-09-30	2010-04-08	Teva Pharmaceutical Industries Ltd.	Crystalline forms of dexlansoprazole
IT1391776B1 (it)	2008-11-18	2012-01-27	Dipharma Francis Srl	Procedimento per la preparazione di dexlansoprazolo
IT1392813B1 (it) *	2009-02-06	2012-03-23	Dipharma Francis Srl	Forme cristalline di dexlansoprazolo
US20110009637A1 (en) *	2009-02-10	2011-01-13	Dario Braga	Crystals of Dexlansoprazole
WO2011004387A2 (en)	2009-06-18	2011-01-13	Matrix Laboratories Ltd	Process for the preparation of dexlansoprazole polymorphic forms
IT1395118B1 (it)	2009-07-29	2012-09-05	Dipharma Francis Srl	Procedimento per la preparazione di dexlansoprazolo cristallino
US20130197232A1 (en) *	2010-01-29	2013-08-01	Ranbaxy Laboratories Limited	Process for the preparation of crystalline forms of dexlansoprazole
US8853411B2 (en)	2010-03-31	2014-10-07	Ranbaxy Laboratories Limited	Process for the preparation of dexlansoprazole
EP2552903A1 (en)	2010-03-31	2013-02-06	Ranbaxy Laboratories Limited	Salts of dexlansoprazole and their preparation
SG190717A1 (en)	2010-12-03	2013-07-31	Takeda Pharmaceutical	Orally disintegrating tablet
MX2013007588A (es)	2010-12-27	2013-08-09	Takeda Pharmaceutical	Comprimido de desintegracion oral.
WO2012104805A1 (en)	2011-02-01	2012-08-09	Ranbaxy Laboratories Limited	Process for the preparation of dexlansoprazole
US20140357870A1 (en)	2011-06-21	2014-12-04	Ranbaxy Laboratories Limited	Process for the preparation of dexlansoprazole
CN102234265B (zh) *	2011-08-08	2013-11-20	天津市汉康医药生物技术有限公司	兰索拉唑化合物
KR101952478B1 (ko)	2011-11-30	2019-02-26	다케다 야쿠힌 고교 가부시키가이샤	유핵정
WO2013140120A1 (en)	2012-03-22	2013-09-26	Cipla Limited	Glycerol solvate forms of (r) - 2 - [ [ [3 -methyl -4 (2,2, 2 - trifluoroethoxy) pyridin- 2 - yl] methyl] sulphinyl] - 1h - ben zimidazole
WO2013179194A1 (en)	2012-05-31	2013-12-05	Ranbaxy Laboratories Limited	Process for the preparation of crystalline dexlansoprazole
CA2913106A1 (en)	2013-05-21	2014-11-27	Takeda Pharmaceutical Company Limited	Orally disintegrable tablet
DE102014109120B4 (de)	2014-06-30	2017-04-06	Krohne Messtechnik Gmbh	Mikrowellenmodul
CN109111430B (zh) *	2017-06-26	2022-09-30	江苏豪森药业集团有限公司	一种右兰索拉唑晶型a及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6150978A (ja)	1984-08-16	1986-03-13	Takeda Chem Ind Ltd	ピリジン誘導体およびその製造法
DK171989B1 (da) *	1987-08-04	1997-09-08	Takeda Chemical Industries Ltd	Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
DE4035455A1 (de)	1990-11-08	1992-05-14	Byk Gulden Lomberg Chem Fab	Enantiomerentrennung
SE504459C2 (sv)	1994-07-15	1997-02-17	Astra Ab	Förfarande för framställning av substituerade sulfoxider
GB9423968D0 (en)	1994-11-28	1995-01-11	Astra Ab	Resolution
HRP960232A2 (en)	1995-07-03	1998-02-28	Astra Ab	A process for the optical purification of compounds
TW385306B (en)	1996-11-14	2000-03-21	Takeda Chemical Industries Ltd	Method for producing crystals of benzimidazole derivatives
SE510666C2 (sv) *	1996-12-20	1999-06-14	Astra Ab	Nya Kristallmodifikationer
JP3929607B2 (ja)	1997-07-23	2007-06-13	エーザイ・アール・アンド・ディー・マネジメント株式会社	ピリジン誘導体の製造方法
JP2002501897A (ja)	1998-01-30	2002-01-22	セプラコール，インク．	Ｒ−ランソプラゾール組成物及び方法
EP1056457A4 (en)	1998-01-30	2006-10-25	Sepracor Inc	S-LANSOPRAZOLE COMPOSITIONS AND METHODS OF USE
CN1087739C (zh)	1998-12-28	2002-07-17	中国科学院成都有机化学研究所	光学纯的苯并咪唑类抗消化性溃疡药物的包结拆分制备法
TWI289557B (en) *	1999-06-17	2007-11-11	Takeda Chemical Industries Ltd	A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
EP1191025B1 (en) *	1999-06-30	2005-06-22	Takeda Pharmaceutical Company Limited	Crystals of lansoprazole
CN100562318C (zh) *	2000-05-15	2009-11-25	武田药品工业株式会社	晶体的制备方法
TWI290922B (en) *	2000-12-01	2007-12-11	Takeda Chemical Industries Ltd	Production method of crystals
EP1945623A2 (en) *	2005-11-10	2008-07-23	Wyeth a Corporation of the State of Delaware	Polymorphs of 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and methods of making the same

2001
- 2001-05-15 CN CNB2005101310114A patent/CN100562318C/zh not_active Expired - Lifetime
- 2001-05-15 EP EP07120887.0A patent/EP1897877B1/en not_active Expired - Lifetime
- 2001-05-15 KR KR1020097010290A patent/KR101035534B1/ko not_active Expired - Fee Related
- 2001-05-15 ES ES10180351.8T patent/ES2521690T3/es not_active Expired - Lifetime
- 2001-05-15 EP EP01930131A patent/EP1293507B1/en not_active Expired - Lifetime
- 2001-05-15 DE DE60131649T patent/DE60131649T2/de not_active Expired - Lifetime
- 2001-05-15 AU AU2001256732A patent/AU2001256732A1/en not_active Abandoned
- 2001-05-15 CA CA2762960A patent/CA2762960C/en not_active Expired - Lifetime
- 2001-05-15 US US10/275,334 patent/US7169799B2/en not_active Expired - Lifetime
- 2001-05-15 KR KR1020087014246A patent/KR20080067713A/ko not_active Ceased
- 2001-05-15 CA CA2409044A patent/CA2409044C/en not_active Expired - Lifetime
- 2001-05-15 PT PT01930131T patent/PT1293507E/pt unknown
- 2001-05-15 ES ES01930131T patent/ES2293988T3/es not_active Expired - Lifetime
- 2001-05-15 WO PCT/JP2001/004014 patent/WO2001087874A1/ja not_active Ceased
- 2001-05-15 CA CA2701704A patent/CA2701704C/en not_active Expired - Lifetime
- 2001-05-15 EP EP10180351.8A patent/EP2281821B1/en not_active Expired - Lifetime
- 2001-05-15 DK DK01930131T patent/DK1293507T3/da active
- 2001-05-15 ES ES07120887.0T patent/ES2511774T3/es not_active Expired - Lifetime
- 2001-05-15 CN CNB018113729A patent/CN1280287C/zh not_active Expired - Lifetime
2006
- 2006-09-05 US US11/515,639 patent/US7569696B2/en not_active Expired - Lifetime
2008
- 2008-02-14 CY CY20081100182T patent/CY1107198T1/el unknown
2009
- 2009-06-26 US US12/492,735 patent/US7994332B2/en not_active Expired - Fee Related
2011
- 2011-06-24 US US13/168,121 patent/US8212046B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7569696B2 (en)	2009-08-04
ES2511774T3 (es)	2014-10-23
PT1293507E (pt)	2008-01-16
US20070004779A1 (en)	2007-01-04
EP1293507A1 (en)	2003-03-19
KR20090076980A (ko)	2009-07-13
KR101035534B1 (ko)	2011-05-23
EP1897877B1 (en)	2014-09-24
EP1293507A4 (en)	2005-09-07
US20030153766A1 (en)	2003-08-14
CA2409044A1 (en)	2002-11-14
KR20080067713A (ko)	2008-07-21
CN100562318C (zh)	2009-11-25
CA2701704C (en)	2011-09-06
DE60131649T2 (de)	2008-10-30
EP1897877A3 (en)	2008-12-10
EP2281821B1 (en)	2014-10-22
CY1107198T1 (el)	2012-11-21
US7994332B2 (en)	2011-08-09
CA2762960A1 (en)	2001-11-22
EP1293507B1 (en)	2007-11-28
US20110257405A1 (en)	2011-10-20
DE60131649D1 (de)	2008-01-10
CN1803137A (zh)	2006-07-19
EP2281821A1 (en)	2011-02-09
CA2762960C (en)	2014-07-22
ES2521690T3 (es)	2014-11-13
ES2293988T3 (es)	2008-04-01
AU2001256732A1 (en)	2001-11-26
US7169799B2 (en)	2007-01-30
WO2001087874A1 (en)	2001-11-22
CN1280287C (zh)	2006-10-18
US20100004458A1 (en)	2010-01-07
CA2409044C (en)	2013-02-19
EP1897877A2 (en)	2008-03-12
US8212046B2 (en)	2012-07-03
CN1437592A (zh)	2003-08-20
CA2701704A1 (en)	2001-11-22

Publication	Publication Date	Title
DK1293507T3 (da)	2007-12-27	Fremgangsmåde til fremstilling af krystaller
DK1303478T3 (da)	2004-08-30	Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1161426T3 (da)	2007-10-08	Fremgangsmåde til fremstilling af furfural
DK1182261T3 (da)	2011-05-16	Fremgangsmåde til frembringelse af basisk aminosyre
DK1296935T3 (da)	2009-06-22	Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1180544T3 (da)	2006-10-23	Fremgangsmåde til fremstilling af syntesegas
DK1296656T3 (da)	2006-11-27	Fremgangsmåde til fremstilling af et præparat
DK1277722T3 (da)	2005-04-25	Fremgangsmåde til fremstilling af methanol
DK1412459T3 (da)	2007-11-26	Fremgangsmåde til fremstilling af mellemdestillater
DK1467993T3 (da)	2008-11-10	Fremgangsmåde til fremstilling af scopinestere
FI20002836L (fi)	2002-06-23	Menetelmä oskillaattorin säätämiseksi
DK1309581T3 (da)	2005-03-14	Fremgangsmåde til fremstilling af citalopram
DK1309545T3 (da)	2007-10-29	Fremgangsmåde til fremstilling af alkylarylsulfonater
FI20002652L (fi)	2002-06-05	Menetelmä suodattimen virittämiseksi
DK1407037T3 (da)	2006-05-22	Fremgangsmåde til fremstilling af tagatose
DK1353923T3 (da)	2005-01-31	Forbedret fremgangsmåde til syntese af carbapenem
DK1272489T3 (da)	2003-12-15	Fremgangsmåde til præparation af cabergolins krystallinske form I
NO20041850L (no)	2004-05-05	Fremgangsmate for dannelse av profenkrystaller
DE10196082T1 (de)	2003-03-13	FLIP-CHIP-Montageverfahren
DK1326836T3 (da)	2004-06-01	Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DE60130137D1 (de)	2007-10-04	Kristallisationsverfahren
IS6716A (is)	2003-02-13	Aðferðir við að framleiða sílostasól
DK1296970T3 (da)	2008-07-14	Fremgangsmåde til fremstilling af citalopram
DK1395587T3 (da)	2009-10-12	Fremgangsmåde til fremstilling af imipenem
DK1286940T3 (da)	2006-07-31	Fremgangsmåde til fluormethylering af alkoholer